Table 2.

Baseline characteristics of RFA and SBRT treatment on different multifocal lesions¹

Patient No.	Lesion No.	Size (mm)	Segmental location	Treatment modalities	Reason for choosing SBRT
1	1	11	5	RFA	Close to diaphragm and hepatic vein
	2	40	7	SBRT
2	3	22	2	RFA	Close to dome of diaphragm
	4	25	8	SBRT
3	5	18	7	RFA	Adjacent to portal vein
	6	33	8	SBRT
4	7	13	8	RFA	Unavoidable hepatic vein (> 3 mm in diameter) in puncture path
	8	11	8	RFA
	9	7	8	RFA
	10	14	1	SBRT
	11	11	1	SBRT
5	12	10	5	RFA	Adjacent to portal vein
	13	14	2	SBRT
6	14	12	8	RFA	Large size and close to dome
	15	12	8	RFA
	16	40	8	SBRT
7	17	18	6	RFA	Close to dome of diaphragm
	18	20	4	SBRT
8	19	18	3	RFA	5 mm distance from heart
	20	9	8	RFA
	21	10	8	RFA
	22	17	4	SBRT
9	23	20	8	RFA	Close to dome of diaphragm
	24	10	4	RFA
	25	8	8	RFA
	26	11	8	SBRT
10	27	21	3	RFA	Close to dome of diaphragm
	28	17	7	SBRT
11	29	16	8	RFA	Undetectable in US and unclear in CEUS
	30	22	7	SBRT
12	31	11	6	RFA	Close to dome of diaphragm
	32	32	8	SBRT
13	33	10	7	RFA	Close to dome of diaphragm
	34	17	7	SBRT
14	35	17	8	RFA	Close to dome of diaphragm
	36	17	8	RFA
	37	8	4	SBRT
15	38	15	6	RFA	Close to heart
	39	10	3	SBRT
Total 2	/	16.6 (7–40)	2/2/3/4/2/3/6/17	23/16	/

¹ HCC: Hepatocellular carcinoma; RFA: radiofrequency ablation; SBRT: stereotactic body radiotherapy; US: ultrasound; CEUS: contrast-enhanced US

² In this line, the order of segmental location is 1 to 8. The order of treatment modalities was RFA and SBRT. The value of size is displayed as mean and range